SCROLL DOWN FOR THE LATEST PRESS RELEASES AND TWEETS - For media enquiries about any aspect of the work of the PMCPA please contact the Press Office via the switchboard: 020 7747 8880 or email us at email@example.com - Sign up for eAlerts at the top of the page and follow us on Twitter @PMCPAUK
The PMCPA publishes certain Sanctions (advertisements, public reprimands and corrective statements) Press Releases and Case Reports.
- the carrying out by the PMCPA of an audit of a company’s procedures to comply with the Code. This can also be followed by a requirement that promotional material be submitted to the PMCPA for pre-vetting for a specified period
- requiring the company to take steps to recover items from those to whom they have been given
- requiring the company to issue a corrective statement
- a public reprimand
- suspension or expulsion from membership of the ABPI.
Where companies are ruled in breach of Clause 2 of the Code, and/or are required to issue a corrective statement and/or are the subject of a public reprimand, the PMCPA advertises brief details of the cases in the medical, nursing and pharmaceutical press, the advertisements are also published on this website.
Case Reports (access Case Reports here)
As mentioned above, in some cases a company may be required to issue a corrective statement or may be the subject of a public reprimand or advertisements in the medical and pharmaceutical press.
Leo, Janssen, Teva, Lundbeck, Otsuka Europe, Daiichi-Sankyo, and Roche named in advertisements for breaches of the ABPI Code
21 April 2022read more
Britannia, AstraZeneca, Allergan, GlaxoSmithKline and Sanofi named in advertisements for breaches of the ABPI Code
16 March 2022read more
New PMCPA Director appointed
23 February 2022read more
Vacancies for independent members of the Code of Practice Appeal Board
20 January 2022read more
The PMCPA is recruiting
13 January 2022read more
Novartis, Camurus, Pfizer and Boehringer Ingelheim have been named in advertisements for breaches of the ABPI Code
21 October 2021read more